SET7/9 promotes hepatocellular carcinoma progression through regulation of E2F1
Open Access
- 2 August 2018
- journal article
- research article
- Published by Spandidos Publications in Oncology Reports
- Vol. 40 (4) , 1863-1874
Abstract
Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies worldwide. Histone‑lysine N‑methyltransferase SET7/9 is a protein lysine monomethylase that methylates histone H3K4 as well as various non‑histone proteins. Deregulation of SET7/9 is frequently detected in human cancers. However, the role of SET7/9 in HCC development remains unclear. In the present study, upregulation of SET7/9 and E2F transcription factor 1 (E2F1) expression was detected in 68 samples of HCC tissues compared with these levels noted in the paired healthy liver samples. The expression levels of SET7/9 and E2F1 were significantly correlated with pathological stage and tumor size. Subcellular fractionation and co‑immunoprecipitation analyses revealed protein‑protein interaction between SET7/9 and E2F1 in the cytoplasm of HCC cells. Silencing of SET7/9, as well as treatment with 5'‑deoxy‑5'‑methylthioadenosine (MTA), a protein methylation inhibitor, led to reduced E2F1 protein abundance in HCC cells. Using Cell Counting Kit‑8 (CCK‑8) assay, Transwell migration assay and wound healing assay, significantly decreased cell proliferation, migration and invasion were observed in cells exhibiting downregulation of SET7/9 and E2F1 expression, as well as in wild‑type HCC cells treated with MTA. Furthermore, SET7/9 downregulation and MTA treatment resulted in reduced expression of downstream targets of E2F1, including cyclin A2, cyclin E1 and CDK2. In conclusion, the present study revealed an oncogenic function of SET7/9 in HCC and demonstrated that SET7/9 may be responsible for alterations in the proliferative ability, aggressiveness and invasive/metastatic potential of HCC cells through post‑translational regulation of E2F1.Keywords
This publication has 40 references indexed in Scilit:
- The transcription factor GATA1 and the histone methyltransferase SET7 interact to promote VEGF-mediated angiogenesis and tumor growth and predict clinical outcome of breast cancerOncotarget, 2016
- KMT Set7/9 affects genotoxic stress response via the Mdm2 axisOncotarget, 2015
- SET7/9 regulates cancer cell proliferation by influencing β‐catenin stabilityThe FASEB Journal, 2015
- Hepatocellular carcinoma: clinical frontiers and perspectivesGut, 2014
- Methylation of SUV39H1 by SET7/9 results in heterochromatin relaxation and genome instabilityProceedings of the National Academy of Sciences, 2013
- Methylation-mediated regulation of E2F1 in DNA damage-induced cell deathJournal of Receptors and Signal Transduction, 2011
- Lysine Methylation Regulates E2F1-Induced Cell DeathMolecular Cell, 2010
- Extracellular signal-regulated kinase induces cyclin D1 and Cdk-2 expression and phosphorylation of retinoblastoma in hepatocellular carcinoma.International Journal of Oncology, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Role for the p53 homologue p73 in E2F-1-induced apoptosisNature, 2000